Related Articles
Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules
Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma
Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma
Prognostic implications of the BRAF‑V600E mutation in papillary thyroid carcinoma based on a new cut‑off age stratification